Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 1546 AL 1560

Cerebrovascular assessment for the risk prediction of Alzheimer's disease

Silvestrini M, Viticchi G, Altamura C, Luzzi S, Balucani C, Vernieri F.

J Alzheimers Dis. 2012;32(3):689-98. doi: 10.3233/JAD-2012-121240.

Epidemiology of Alzheimer disease

Mayeux R, Stern Y.

Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a006239. doi: 10.1101/cshperspect.a006239.

Metabolic syndrome, mild cognitive impairment and Alzheimer's disease--the emerging role of systemic low-grade inflammation and adiposity

Misiak B, Leszek J, Kiejna A.

Brain Res Bull. 2012 Nov 1;89(3-4):144-9. doi: 10.1016/j.brainresbull.2012.08.003. Epub 2012 Aug 18.

Use of the MC-FAQ and MMSE-FAQ in cognitive screening of older African Americans, Hispanic Americans, and European Americans

Tappen RM, Rosselli M, Engstrom G.

Am J Geriatr Psychiatry. 2012 Nov;20(11):955-62. doi: 10.1097/JGP.0b013e31825d0935.

Overlapped metabolic and therapeutic links between Alzheimer and diabetes

Ahmad W.

Mol Neurobiol. 2013 Feb;47(1):399-424. doi: 10.1007/s12035-012-8352-z. Epub 2012 Sep 26.

Size frequency distributions of β-amyloid (Aβ) deposits: a comparative study of four neurodegenerative disorders

Armstrong RA.

Folia Neuropathol. 2012;50(3):240-9. doi: 10.5114/fn.2012.30524.

Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer's disease

Leszek J, Sochocka M, Gąsiorowski K.

J Neurol Sci. 2012 Dec 15;323(1-2):25-32. doi: 10.1016/j.jns.2012.09.010. Epub 2012 Sep 29.

Visual contrast sensitivity in Alzheimer's disease, mild cognitive impairment, and older adults with cognitive complaints

Risacher SL, Wudunn D, Pepin SM, MaGee TR, McDonald BC, Flashman LA, Wishart HA, Pixley HS, Rabin LA, Paré N, Englert JJ, Schwartz E, Curtain JR, West JD, O'Neill DP, Santulli RB, Newman RW, Saykin AJ.

Neurobiol Aging. 2013 Apr;34(4):1133-44. doi: 10.1016/j.neurobiolaging.2012.08.007. Epub 2012 Oct 18.

[Alzheimer's disease and fragile X syndrome: the Wnt/ß-catenin pathway as a common biological mechanism]

Rosales-Reynoso MA, Ochoa-Hernández AB, Juárez-Vázquez CI, Barros-Núñez P.

Rev Neurol. 2012 Nov 1;55(9):543-8.

[Genetics and Alzheimer's disease: a population at risk]

Fernández-Viadero C, Rodríguez Rodríguez E, Combarros Pascual O, Crespo Santiago D.

Rev Esp Geriatr Gerontol. 2013 Jan-Feb;48(1):39-44. doi: 10.1016/j.regg.2012.03.004. Epub 2012 Oct 31.

Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment

Grill JD, Karlawish J, Elashoff D, Vickrey BG.

Alzheimers Dement. 2013 May;9(3):356-359.e1. doi: 10.1016/j.jalz.2012.03.001. Epub 2012 Nov 8.

Epidemiology of dementias and Alzheimer's disease

Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ.

Arch Med Res. 2012 Nov;43(8):600-8. doi: 10.1016/j.arcmed.2012.11.003. Epub 2012 Nov 15.

The impact of alcohol on Alzheimer's disease: a systematic review

Piazza-Gardner AK, Gaffud TJ, Barry AE.

Aging Ment Health. 2013;17(2):133-46. doi: 10.1080/13607863.2012.742488. Epub 2012 Nov 21.

Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD

Mendez MF.

Arch Med Res. 2012 Nov;43(8):677-85. doi: 10.1016/j.arcmed.2012.11.009. Epub 2012 Nov 21.

Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade

Honjo K, Black SE, Verhoeff NP.

Can J Neurol Sci. 2012 Nov;39(6):712-28. doi: 10.1017/s0317167100015547.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias